Windsor Creek Advisors’s Twist Bioscience TWST Stock Holding History

Windsor Creek Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400	Closed	-$43K	–	127
2021 Q3	$43K	Buy	+400	New	+$45.8K	0.01%	121
2020 Q2	–	Sell	-16,503	Closed	-$505K	–	207
2020 Q1	$505K	Sell	16,503 -11,105	-40%	-$299K	0.18%	106
2019 Q4	$580	Sell	27,608 -27,960	-50%	-$654K	0.15%	93
2019 Q3	$1.33M	Buy	55,568 +24,868	+81%	+$723K	0.33%	61
2019 Q2	$891K	Buy	+30,700	New	+$812K	0.24%	75

Other funds holding TWST

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Windsor Creek Advisors's TWST Position: Q4 2021 in Review

Windsor Creek Advisors sold out of Twist Bioscience (TWST) in Q4 2021, closing a stake of 400 shares — an estimated $43K sold.

Windsor Creek Advisors first reported a position in TWST in Q2 2019 and held it in 5 quarters. The position peaked at $1.33M in Q3 2019. 236 funds tracked by Wall St. Rank hold TWST as of Q4 2021.

Windsor Creek Advisors reported no remaining Twist Bioscience position as of Q4 2021 after selling out during the quarter.
Windsor Creek Advisors sold 400 Twist Bioscience shares in Q4 2021, an estimated $43K.
Windsor Creek Advisors first reported a position in Twist Bioscience in Q2 2019 and held it in 5 quarters.
Windsor Creek Advisors's Twist Bioscience position peaked at $1.33M in Q3 2019.
236 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2021.

Based on Windsor Creek Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.